Thank you for attending the event and for your interest in the Finnish innovations! We hope that the discussions continue after the event.
A warm welcome to the third virtual investor event to meet the most prominent Finnish health and life science focused research groups! The event is invite-only and free-of-charge for international and Finnish investors.
During the online event, you will have an opportunity to:
The research groups are selected by Business Finland in cooperation with the Finnish universities, and you can find the details of the research groups below.
Register now, and you are all set to start booking 1-to-1 virtual meetings with the research groups.
The event is organised by:
The event is organized online and in two parts according to theme. You can choose to participate on both days, or just one.
Wednesday, 30 November:
Life Sciences and Biotech
13:00-13:10 EET/
11:00-11:10 GMT
Welcome words:
Sampo Sammalisto (host), Head of Personalized Health Finland, Business Finland
Research to Business Funding:
Outi Keski-Äijö, Ecosystem Lead, AI, Data & Quantum, Business Finland
13:10-15:15 EET/
11:10-13:15 GMT
Pitches by the research groups
15:30-20:00 EET/
13:30-18:00 GMT
Virtual 1-to-1 meetings
Thursday, 1 December:
Digital Health, MedTech & Diagnostics
13:00-13:10 EET /
11:00-11:10 GMT
Welcome words:
Tarja Enala (host), Senior Advisor, Health and Wellbeing, Invest in Finland at Business Finland
Reseach to Business Funding:
Jaana Rantanen, Senior Adviser, Business Finland
13:10-15:45 EET /
11:10-13:45 GMT
Pitches by the research groups
16:00-20:00 EET /
14:00-18:00 GMT
Virtual 1-to-1 meetings
Friday, 2 December:
Virtual meetings continue
09:00-15:00 EET /
07:00-13:00 GMT
Additional time slots for virtual 1-to-1 meetings
*Slight delays may occur during the event.
13:13 EET
11:13 GMT
EPLINEx
Early detection of aggressive cancer and novel biomarker-guided cancer treatment. The biggest challenge in hospitals treating patients with HNSCC (head and neck squamous cell carcinoma) is the lack of biomarkers that could be used in cancer treatment planning, disease progression monitoring, or in predicting treatment response. In our recent studies, we have been able to develop a very promising method (EPLINEx) to identify metastatic HNSCC cancer at an early stage.
Presenter: Sami Ventelä
Contact: sami.ventela@utu.fi, matti juvonen@utu.fi
University: University of Turku
Life Sciences / Diagnostics
13:21 EET
11:21 GMT
3D-FLUOHISTO Novel 3D histology solutions for life science, pharma and biotech
3D FLUOHISTO brings into use the latest technology to enable advanced approach for tissue analysis in the means of providing leading 3 D histology analysis services. It is our mission to provide life science, pharma, biotech and hospitals remarkably efficient and accurate solutions by leveraging 3 D histology.
Presenter: Miika Niemeläinen
Contact: miika.niemelainen@utu.fi, ilkka.paatero@utu.fi
University: University of Turku
Life Sciences / Biotech
13:30 EET
11:30 GMT
Integrated Secretion Solutions (ISS)
Boosting therapeutic protein production.
Presenter: Ville Paavilainen
Contact: ville.paavilainen@helsinki.fi, katja.rosti@helsinki.fi
University: University of Helsinki
Life Sciences / Biotech
13:39 EET
11:39 GMT
RevEye
From fundamental ocular surface research to the commercialization of a novel dry eye treatment.
Presenter: Kari Lehmussaari
Contact: kari.lehmussaari@helsinki.fi, marika.ruponen@helsinki.fi, filip.ekholm@helsinki.fi
University: University of Helsinki
Life Sciences / Biotech
13:48 EET
11:48 GMT
GlobeVAC
A thermostable vaccine formulation for global immunisation.
Presenter: Manlio Fusciello
Contact: manlio.fusciello@helsinki.fi, vincenzo.cerullo@helsinki.fi
University: University of Helsinki
Life Sciences / Biotech
13:57-14:15 EET
11:57-12:15 GMT
BREAK
14:16 EET
12:16 GMT
Glue4Life – Next generation bioinks for printing life
Our bioink innovation, Glue4Life, is a next generation bioink for 3D bioprinting of living tissues and organs. We envision to advance the development of artificial tissues and organs for future clinical applications by offering bioinks manufactured with clinically compatible components.
Presenter: Paula Puistola
Contact: paula.puistola@tuni.fi, anni.moro@tuni.fi
University: Tampere University
Life Sciences / Biotech
14:25 EET
12:25 GMT
MEMO
MEMO project is devoted for the concept proof (verification and validation) studies on the novel enabling technology based on innovative brain-on-chip principle for the modeling of epileptic seizures, and striving for the commercialization of technology to global drug discovery markets.
Presenter: Satu Jäntti
Contact: susanna.narkilahti@tuni.fi, satu.jantti@tuni.fi
University: Tampere University
Life Sciences / Biotech
14:34 EET
12:34 GMT
Arivin Therapeutics
To mitigate infectious diseases and antimicrobial resistance. A lead opportunity has been identified in developing a treatment for chronic Pseudomonas aeruginosa in Cystic Fibrosis.
Presenter: Christopher Jonkergouw
Contact: christopher.jonkergouw@aalto.fi
University: Aalto University
Life Sciences / Biotech
14:43 EET
12:43 GMT
Moncyte
Moncyte test sheds light on why some people respond differently to cholesterol-lowering drugs, opening new ways for personalized medicine and improving patient lives.
Presenter: Simon Pfisterer
Contact: simon.pfisterer@helsinki.fi
University: University of Helsinki
Diagnostics
14:52 EET
12:52 GMT
Immunate
Immunate develops microscopy technology with the goal of significantly enhancing the adoptability of 3D cell culture in research and industry.
Presenter: Margita Engström
Contact: margita.engstrom@gmail.com, juho.pokki@aalto.fi
University: Aalto University
Diagnostics
15:01 EET
13:01 GMT
Urisens
Urine parameters will be measured with printed sensors. They provide automated urine assessment for diagnostic support.
Presenter: Oguz Tanzer
Contact: oguz.tanzer@aalto.fi
University: Aalto University
Diagnostics
15:10 EET
13:10 GMT
CLOSING WORDS & BREAK
15:30 EET
13:30 GMT
MATCHMAKING STARTS
13:12 EET
11:12 GMT
mTMS
AI-utilizing multi-locus transcranial magnetic stimulation (TMS) technology that will enable new closed-loop, feed-back-controlled brain therapy. Huge therapeutic benefits may be obtained, saving the EU area even one billion euros from the annual costs of brain disorders.
Presenter: Dubravko Kicic
Contact: dubravko.kicic@aalto.fi, thomas.lemstrom@aalto.fi, jaakko.nieminen@aalto.fi
University: Aalto University
MedTech / Diagnostics
13:21 EET
11:21 GMT
MEGMRI
MEG-MRI scanner performs functional and structural imaging in a single study. Hybrid MEG-MRI Brain Scanner provides simpler workflow and up to 95% less error.
Presenter: Marko Havu
Contact: marko.havu@aalto.fi, thomas.lemstrom@aalto.fi
University: Aalto University
Diagnostics
13:30 EET
11:30 GMT
Detecor
Detection of corrosion from stainless steel medical instruments in hospitals.
Presenter: Juho Lehmusto
Contact: juho.lehmusto@abo.fi, mikael.bergelin@abo.fi, leena.hupa@abo.fi
Research organisation: Åbo Akademi
Diagnostics
13:39 EET
11:39 GMT
MoreStamina
An evidence-based fatigue management solution for persons with Multiple Sclerosis.
Presenter: Guido Giunti Garcia
Contact: guido.giunti@oulu.fi
University: University of Oulu
Digital Health
13:48 EET
11:48 GMT
GARMENT
GARMENT creates a wearable-based platform that connects games to a healthier personalized gamified daily life. The youth is very hooked on screens and lives a sedentary lifestyle, causing medical and health issues in the long term. Our solution is merging games with the daily physical activity of players. Because gaming is a rapidly growing market, youth are looking for more realism and immersion, and parents and organizations look for health solutions. GARMENT offers to bridge daily physical activity and games by creating a platform where players can gain in-game awards based on their physical activity in everyday life.
Presenter: Oğuz “Oz” Buruk
Contact: oguz.buruk@tuni.fi
University: Tampere University
Digital Health
13:57 EET
11:57 GMT
Soihtu DTx
Medical gaming solution for treatment of depression.
Presenter: Joonas Juvonen
Contact: joonas.j.juvonen@aalto.fi, jukka.t.laakso@aalto.fi, sami.k.lehtinen@aalto.fi, matias.palva@aalto.fi
University: Aalto University
Digital Health
14:06 EET
12:06 GMT
BioLiDAR
Next Generation Optical Sport Sensor for Wearable Devices.
Presenter: Jan Nissinen
Contact: jan.nissinen@oulu.fi
University: University of Oulu
Digital Health / MedTech
14:15 EET
12:15 GMT
Emedpatch
Multi-functional, self-sustainable sensing components for smart skin.
Presenter: Yang Bai
Contact: yang.bai@oulu.fi
University: University of Oulu
Digital Health / MedTech
14:25-14:35 EET
12:25-12:35 GMT
BREAK
14:35 EET
12:35 GMT
Mukava
The measurement of biopotential signals (such as ECG and EEG) is a widely employed method in health-care for illness diagnosis and patient state monitoring as well as in sport and wellbeing sectors to track performance, recovery, and physiological state of the body. The existing mainstream method to realize the electrical contact to skin is via disposable pregelled Ag/AgCl electrodes. Despite of market domination pregelled Ag/AgCl electrodes have many shortcomings such as skin irritation, wear discomfort, limited bandwidth and price point. VTT has invented and patented novel graphene based dry electrode solution which provides excellent signal quality and user comfort while being cheap and reliable in long-them measurements, thus eliminating all the pain points of hydrogel electrodes.
Presenter: Teemu Ruotsalainen
Contact: teemu.ruotsalainen@vtt.fi
University: VTT Technical Research Centre
MedTech
14:44 EET
12:44 GMT
Medixmicro
Replacing injections – Creating value for healthcare chain with painless microneedle therapies.
Presenter: Antti Rahikkala
Contact: antti.rahikkala@helsinki.fi
University: University of Helsinki
MedTech
14:53 EET
12:53 GMT
CorFlux – Digital twin analysis for improving the life expectancy of aortic aneurysm patients
The diagnosis, treatment and monitoring of aortic aneurysms cause significant costs for worldwide healthcare systems and economies. CorFlux analysis is a completely new approach for assessing the criticality of aortic aneurysms. The analysis will enable healthcare professionals to make decisions related to the treatment of aortic aneurysm patients much more accurately than the current practice.
Presenter: Tero Puustinen
Contact: tero.puustinen@uef.fi, matti.hoyto@uef.fi
University: University of Eastern Finland
MedTech / Health tech
15:02 EET
13:02 GMT
Glymphometer
Wearable device for monitoring glymphatic function in brain.
Presenter: Teemu Myllylä
Contact: teemu.myllyla@oulu.fi
University: University of Oulu
MedTech / Diagnostics
15:11 EET
13:11 GMT
Nosore
How to estimate the risk for bed patient to get pressure ulcers. By measuring various physical parameters and using clever algorithm, the risk can be indicated and the nurses can take necessary actions.
Presenter: Martti Vakkala
Contact: martti.vakkala@aalto.fi, nuno.nobre@aalto.fi
University: Aalto University
MedTech / Digital Health
15:20 EET
13:20 GMT
HentoTouch
How to treat alcoholism, especially how to prevent new “drinking lapses”. Idea is to right kind of generate haptic touch-based stimulus which will then cause the brain to produce dopamine (or similar).
Presenter: Jukka Planman
Contact: jukka.planman@aalto.fi, julianna.harkki@aalto.fi, pauli.tuovinen@aalto.fi
University: Aalto University
MedTech / Digital Health / Diagnostics
15:29 EET
13:29 GMT
CLOSING WORDS & BREAK
16:00 EET
14:00 GMT
MATCHMAKING STARTS
Health Capital Helsinki
https://healthcapitalhelsinki.fi/wp-content/uploads/2024/10/EsaDres-team-2024.jpg
1016
2200
Saana Lehtinen
https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png
Saana Lehtinen2024-12-10 08:03:222024-12-12 14:13:44EsaDres redefines wound care with tailored solutions
https://healthcapitalhelsinki.fi/wp-content/uploads/2024/12/natal_mind_team.jpg
1089
1812
Saana Lehtinen
https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png
Saana Lehtinen2024-12-08 19:40:232024-12-08 20:01:51Natal Mind is on a mission to revolutionise parental mental care
https://healthcapitalhelsinki.fi/wp-content/uploads/2024/11/Ankerias_Tiimi-980x735-2.jpg
735
980
Saana Lehtinen
https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png
Saana Lehtinen2024-11-04 10:39:162024-11-08 11:25:48Ankerias is revolutionising chronic pain treatment with AI
